Zydus Lifesciences shares rose nearly 2% to Rs 899.40 after receiving USFDA approval to manufacture Eluxadoline Tablets (75 ...

Nuvama is of the view that the Zydus Life's latest deal would be dilutive to the company's Earnings Per Share (EPS) by 1% to ...

The rise in the Zydus Lifesciences shares came after the company received final approval from the United States Food and Drug ...

Eluxadoline tablets will be produced at Zydus Lifesciences Ltd (SEZ) in Ahmedabad, the company said in an exchange filing.

Zydus Lifesciences shares rose 8.34 per cent on March 19, touching an intraday high of Rs 910.30  at 1:00 PM when the company ...

Zydus Lifesciences said that it has received final approval from the United States Food and Drug Administration (US FDA) to manufacture Apalutamide tablets, 60 mg.

Zydus Lifesciences announced it is negotiating to acquire a majority stake in French medtech firm Amplitude Surgical for ...

Zydus Lifesciences rose 3% to an intra-day high of Rs 930 after the company received approval from the US FDA to manufacture ...

Brokerages deemed Zydus Life's acquisition of Amplitude Surgical as expensive, with subpar synergies that has triggered ...

As of June 30, 2024, Amplitude Surgical reported a turnover of €106 million (Rs 1,000 crore) Zydus Life in the first leg, will buyout key shareholders and later it plans to make an open offer to ...